当前位置：首页 > 文献互助 > 互助详情

Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors复制

用户RcsoTKlzyIwM 15分钟前 7 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-30 19:57:33 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: DOI: 10.1016/j.imbio.2022.152283复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0171298522001097复制

其他信息:

出版社: Elsevier BV
作者: Guili Xu; Niliang Qian; Yujie Liu; Hongjie Li; Cuima Yang; Jingjing Wang; Fuyu Wang; Liting Chen; Guijun Bai; Qinzhi Xu; Xiujie Pan; Xin Gao

上一篇：CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

互助时间线

2026-07-23 20:10:51 [完结求助]

楼主确认了生活如歌应助的文件是正确的, 求助状态变成 已完结

2026-07-23 19:57:33 [上传文件]

生活如歌上传了文件(pdf 1.58 MB), 求助状态变成 待确认

2026-07-23 19:56:59 [发起求助]

最新发布的求助

Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors 15分钟前
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation 16分钟前
Photochemical Hydrogen Storage with Hexaazatrinaphthylene 2小时前
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system 2小时前
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes 3小时前
CPX-351: From preclinical studies to future directions 3小时前
Adverse effects of intravenous LNP-mediated mRNA therapy in clinical trials: a systematic review and meta-analysis 4小时前
Safety and mechanism of action of noninvasive radiofrequency treatment for vaginal laxity: Histological study in the swine vaginal model 5小时前
Light-induced damage in semiconductor device manufacturing: Present and future challenges 5小时前
Temporal dynamics of type I interferon signaling in checkpoint inhibitor response and resistance 8小时前
Leveraging Machine Learning To Discover Novel Diagnostic Biomarkers for Breast Cancer 8小时前
Integrating STING activation with programmed death-ligand 1 inhibition: Novel approaches for cancer treatment 9小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com